Open Innovation & Pharma and biotechs

Article Index

Even if it is not on their full business activities, several of the "big" labs clearly implemented an open innovation attitude on several dimensions:

Open Innovation and Learning cycles by Lilly
what is open innovation (by Lilly) learning cycles (by Lilly)


SourceIFPMA "International Federation of Pharmaceutical Manufacturers & Associations"


Download this file (Assembling_the_RD_puzzle_FINAL.pdf)Assembling_the_RD_puzzle_FINAL.pdf[Assembling the pharmaceutical R&D puzzle for needs in the developing world (Putgatch Consilium 2012)]1148 kB
Download this file (CEWG_Report_5_April_2012.pdf)CEWG_Report_5_April_2012.pdf[Report of the Consultative Expert Working Group on Research and Development: Financing and Coordination (WHO - 2012)]1341 kB
Download this file (oidd_potential_path_ctmc.pdf)oidd_potential_path_ctmc.pdf[Open Innovation Drug Discovery (OIDD): A Potential Path to Novel Therapeutic Chemical Space (by Lilly)]1033 kB
Access this URL ([Publications by Lilly on Open Innovation Drug Discovery]0 kB
Download this file (Open-innovation-a-new-paradigm-for-industry-academia-collaboration.pdf)Open-innovation-a-new-paradigm-for-industry-academia-collaboration.pdf[Open innovation: a new paradigm for industry-academia collaboration, by Paul-Peter Tak, Senior Vice President, Head, Immuno Inflammation Therapy Area, GSK, UK (2013)]2861 kB
Access this URL ([Search on \"open Innovation \" in the journal \"Open Medicine\"]0 kB
Access this URL ([OSDD - Open Source Drug Discovery]40 kB